{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:01:33Z","timestamp":1791014493989,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1016\/s0145-2126(02)00327-2","type":"journal-article","created":{"date-parts":[[2003,4,5]],"date-time":"2003-04-05T02:09:52Z","timestamp":1049508592000},"page":"695-699","source":"Crossref","is-referenced-by-count":5,"title":["In vitro thymidine kinase\/ganciclovir-based suicide gene therapy using replication defective herpes simplex virus-1 against leukemic B-cell malignancies (MCL, HCL, B-CLL)"],"prefix":"10.1016","volume":"27","author":[{"given":"Motohiro","family":"Misumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Glorioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Bessho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(02)00327-2_BIB1","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW, editors, Tumors of hematopoietic and lymphoid tissues. World Health Organization classification of tumors. Lyon: IARC Press; 2001."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1016281324761","article-title":"Antigene, ribozyme, and aptamer nucleic acid drugs: progress and prospects","volume":"12","author":"Stull","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB3","doi-asserted-by":"crossref","unstructured":"Walther W, Stein U, editors. Gene therapy of cancer. Clifton: Humana Press; 2000.","DOI":"10.1385\/1592590861"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB4","first-page":"481","article-title":"Development of replication-defective herpes simplex virus vectors","volume":"69","author":"Goins","year":"2002","journal-title":"Methods Mol. Med."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1006\/bbrc.1998.9685","article-title":"Efficient gene delivery into Epstein\u2013Barr virus (EBV)-transformed human B cell mediated by replication defective herpes simplex virus-1 (HSV-1): a gene therapy model for EBV-related B-cell malignancy","volume":"252","author":"Suzuki","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/204793a0","article-title":"Separation of white blood cells","volume":"204","author":"Boyum","year":"1964","journal-title":"Nature"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB7","doi-asserted-by":"crossref","unstructured":"Krisky DM, Marconi PC, Oligino T, Rouse RJ, Fink DJ, Glorioso JC. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther 1997;1120.","DOI":"10.1038\/sj.gt.3300497"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB8","doi-asserted-by":"crossref","first-page":"11319","DOI":"10.1073\/pnas.93.21.11319","article-title":"Replication-defective herpes simplex virus vectors for gene therapy","volume":"93","author":"Marconi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1054-3589(08)60139-8","article-title":"Engineering herpes simplex vectors for human gene therapy","volume":"40","author":"Glorioso","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1359-6446(01)01713-5","article-title":"Multi-model combination gene therapy for malignant glioma using replication-defective HSV vectors","volume":"6","author":"Burton","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB11","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1089\/104303400750038499","article-title":"A phase III clinical evaluation of herpes simplex virus type-1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme","volume":"11","author":"Rainov","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB12","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.gt.3301265","article-title":"HSV vector cytotoxicity is inversely correlated with effective TK\/GCV suicide gene therapy of rat gliosarcoma","volume":"7","author":"Moriuchi","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB13","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0022-5347(05)66512-3","article-title":"Treatment of human renal cell carcinoma by a conditionally replicating herpes vector G207","volume":"165","author":"Oyama","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB14","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1349-7006.2000.tb00923.x","article-title":"Oncolytic viral therapy for human prostate cancer by conditionally replicating herpes simplex virus-1 vector G207","volume":"91","author":"Oyama","year":"2000","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB15","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0003-4975(99)00852-8","article-title":"Oncolytic therapy using a mutant type-1 herpes simplex virus and the role of the immune system","volume":"68","author":"Lambright","year":"1999","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5132","article-title":"High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type-1 vector","volume":"71","author":"Wang","year":"1998","journal-title":"Genecol. Oncol."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB17","first-page":"3969","article-title":"Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors","volume":"61","author":"Yamamura","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB18","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1073\/pnas.101136398","article-title":"Oncocytic herpes simplex vector with enhanced MHC class I presentation and tumor cell killing","volume":"98","author":"Todo","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/viro.1995.1382","article-title":"Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus-1 mutant","volume":"21","author":"Randazzo","year":"1995","journal-title":"Virology"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1091-255X(99)80005-5","article-title":"Influence of p53 on herpes simplex virus type-1 vectors for cancer gene therapy","volume":"3","author":"Yoon","year":"1999","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00000658-199609000-00008","article-title":"Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus","volume":"224","author":"Carroll","year":"1996","journal-title":"Ann. Surg."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/exnr.1996.6395","article-title":"Development of an HSV-based vector for the treatment of Parkinson\u2019s disease","volume":"144","author":"Fink","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-409X(97)00021-5","article-title":"Progress in development of herpes simplex virus gene transfer for the treatment of rheumatoid arthritis","volume":"27","author":"Evans","year":"1997","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood.V98.2.287","article-title":"Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia","volume":"98","author":"Tolba","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB25","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe immunodeficiency by ex vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N. Engl. J. med."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.298.5591.34","article-title":"Clinical research. Gene therapy a suspect in leukemia-like disease","volume":"298","author":"Marshall","year":"2002","journal-title":"Science"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1182\/blood.V89.1.119","article-title":"A novel herpes vector for the high-efficiency transduction of normal and malignant hematopoietic cells","volume":"89","author":"Diloo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB28","first-page":"47","article-title":"Gene transfer to stem cells using herpes simplex virus type-1 (HSV-1) vectors","volume":"1","author":"Wechuck","year":"2001","journal-title":"Mol. Ther. Suppl."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.gt.3301241","article-title":"Chronic lymphocytic leukemia B cell are highly sensitive to infection by herpes simplex virus-1 via herpes virus-entry-mediator A","volume":"7","author":"Eling","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/S0145-2126(02)00327-2_BIB30","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1126\/science.280.5369.1618","article-title":"Entry of alpha-herpes viruses mediated by poliovirus receptor-related protein-1 and poliovirus receptor","volume":"280","author":"Geraghty","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/viro.1998.9218","article-title":"A cell surface protein with herpes virus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type-1, herpes simplex virus type-2, and pseudorabies virus","volume":"246","author":"Warner","year":"1998","journal-title":"Virology"},{"key":"10.1016\/S0145-2126(02)00327-2_BIB32","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1317968","article-title":"In vitro gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors","volume":"256","author":"Culver","year":"1992","journal-title":"Science"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212602003272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212602003272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T10:21:53Z","timestamp":1584526913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212602003272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S0145212602003272"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(02)00327-2","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}